» Articles » PMID: 33967765

Isoliensinine: A Natural Compound with "Drug-Like" Potential

Overview
Journal Front Pharmacol
Date 2021 May 10
PMID 33967765
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Isoliensinine, a bisbenzylisoquinoline alkaloid isolated from Gaertn, exerts a variety of beneficial effects, such as antitumor, cardioprotective, antioxidant, antidepressant, and anti-HIV effects, and ameliorates T2DM with hyperlipidemia and Alzheimer's disease. In this article, the recent literature on isoliensinine, including its pharmacology, pharmacokinetics, and synthesis and extraction, is summarized. Moreover, possible future prospects and research directions are also discussed. Studies on isoliensinine were found by searching a combination of keywords including "pharmacology," "pharmacokinetics," and "synthesis and extraction" in the main databases, including PubMed, Google Scholar, Web of Science, NCBI, and Wan Fang. Many studies have pointed out that a major limitation of isoliensinine is its poor solubility in aqueous media. Considering its advantages and limitations, isoliensinine can be used as a lead compound to develop novel efficient and low-toxicity derivatives. The available literature indicates that isoliensinine displays "drug-like" potential. Additionally, there are many related issues and novel mechanisms that need to be explored.

Citing Articles

Isoliensinine suppressed gastric cancer cell proliferation and migration by targeting TGFBR1 to regulate TGF-β-smad signaling pathways.

Hu J, Dai S, Yuan M, Li F, Xu S, Gao L Front Pharmacol. 2024; 15:1438161.

PMID: 39364054 PMC: 11446791. DOI: 10.3389/fphar.2024.1438161.


High-coverage characterization and discovery of molecular markers for quality control of natural fragrant plant extracts using UPLC-HRMS-based untargeted metabolomics.

Huo J, Zhe W, Zhang Y, Yang Q, Zeng Z Anal Bioanal Chem. 2024; 416(26):5639-5654.

PMID: 39167185 DOI: 10.1007/s00216-024-05478-4.


In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.

Shah M, Yamin R, Ahmad I, Wu G, Jahangir Z, Shamim A PLoS One. 2024; 19(1):e0294769.

PMID: 38175855 PMC: 10766191. DOI: 10.1371/journal.pone.0294769.


Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry.

Dabrell S, Li Y, Yamaguchi H, Chen H, Hung M Biomedicines. 2023; 11(11).

PMID: 38001915 PMC: 10669532. DOI: 10.3390/biomedicines11112914.


Isoliensinine Attenuates Renal Fibrosis and Inhibits TGF-β1/Smad2/3 Signaling Pathway in Spontaneously Hypertensive Rats.

Yao M, Lian D, Wu M, Zhou Y, Fang Y, Zhang S Drug Des Devel Ther. 2023; 17:2749-2762.

PMID: 37701045 PMC: 10494865. DOI: 10.2147/DDDT.S414179.


References
1.
Chen G, Zhu M, Guo M . Research advances in traditional and modern use of : phytochemicals, health promoting activities and beyond. Crit Rev Food Sci Nutr. 2019; 59(sup1):S189-S209. DOI: 10.1080/10408398.2018.1553846. View

2.
Ziegler J, Facchini P . Alkaloid biosynthesis: metabolism and trafficking. Annu Rev Plant Biol. 2008; 59:735-69. DOI: 10.1146/annurev.arplant.59.032607.092730. View

3.
Do T, Nguyen T, Tran H, Stuppner H, Ganzera M . Analysis of alkaloids in Lotus (Nelumbo nucifera Gaertn.) leaves by non-aqueous capillary electrophoresis using ultraviolet and mass spectrometric detection. J Chromatogr A. 2013; 1302:174-80. DOI: 10.1016/j.chroma.2013.06.002. View

4.
Yang X, Huang M, Yang J, Wang J, Zheng S, Ma X . Activity of Isoliensinine in Improving the Symptoms of Type 2 Diabetic Mice via Activation of AMP-Activated Kinase and Regulation of PPARγ. J Agric Food Chem. 2017; 65(33):7168-7178. DOI: 10.1021/acs.jafc.7b01964. View

5.
Barnett R . Alzheimer's disease. Lancet. 2019; 393(10181):1589. DOI: 10.1016/S0140-6736(19)30851-7. View